Skip to Content

J 17 (Lamivudine 300 mg)

Pill with imprint J 17 is White, Capsule-shape and has been identified as Lamivudine 300 mg. It is supplied by Camber Pharmaceuticals, Inc..

Lamivudine is used in the treatment of hepatitis b; hiv infection; nonoccupational exposure; occupational exposure and belongs to the drug class nucleoside reverse transcriptase inhibitors (NRTIs). Risk cannot be ruled out during pregnancy. Lamivudine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for J 17

Lamivudine

Imprint
J 17
Strength
300 mg
Color
White
Shape
Capsule-shape
Availability
Prescription only
Drug Class
Nucleoside reverse transcriptase inhibitors (NRTIs)
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Camber Pharmaceuticals, Inc.
National Drug Code (NDC)
68554-5054

Get help with Imprint Code FAQs.

Related Images for "J 17"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.